Cargando…

P1664: WHICH FACTORS DO IMPACT IN OPTIMAL ANTICOAGULATION IN ANTIPHOSPHOLIPID SYNDROME?

Detalles Bibliográficos
Autores principales:	Ontiveros-Austria, Juan Luis, Rodriguez-Rodriguez, Sergio, Sánchez-Albarrán, José Manuel, Orozco, Alfonso, Luna, Sofía Ávila, Esparza, Aldo Alejandro Silva, Sorsby, Alec Seidman, Bargas, Ana Barrera, Ruiz, Angel Gabriel Vargas, Demichelis, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429949/ http://dx.doi.org/10.1097/01.HS9.0000973528.27834.c5

Ejemplares similares

PB2577: INFECTIONS AND THEIR RELATIONSHIP WITH EARLY MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA
por: Ontiveros-Austria, Juan Luis, et al.
Publicado: (2023)

Reduction in Obesity-Related Hepatic Fibrosis by SR1664
por: McVicker, Benita L., et al.
Publicado: (2023)

1664. The Utilization of Hospital Inpatient Care due to Tuberculosis, Republic of Ireland, 2015-2018
por: O’Connell, James A, et al.
Publicado: (2020)

Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
por: Capecchi, Marco, et al.
Publicado: (2022)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
por: Tripodi, Armando, et al.
Publicado: (2023)

Dysentery as the First Manifestation of Severe COVID-19
por: Seidman-Sorsby, Alec, et al.
Publicado: (2021)

Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination
por: Lambroussis, Constantino G, et al.
Publicado: (2022)

1664 Case Series of Imported Enteric Fever in Japan: Clinical Characteristics, Antibiotics Susceptibility, and Relapse Risk Factors
por: Matono, Takashi, et al.
Publicado: (2014)

1664. Maternal Hookworm Infection and Its Effect on Maternal/Child Health: A Systematic Review and Meta-Analysis
por: Ness, Tara, et al.
Publicado: (2019)

1664. The Impact of Levofloxacin Prophylaxis on Empiric Intravenous Antibiotic Use in Pediatric Hematopoietic Stem Cell Transplant Recipients
por: Prodanuk, Michael, et al.
Publicado: (2023)

PB2627: THROMBOTIC THROMBOCYTOPENIC PURPURA, RELAPSE RELATED RISK FACTORS IN A CARE CENTER WITH LIMITED ACCESS TO ADAMTS13 LEVELS.
por: Goya, Santiago Riviello, et al.
Publicado: (2023)

A Family of Early English Oculists (1600-1751), With a Reappraisal of John Thomas Woolhouse (1664-1733/1734)
por: Leffler, Christopher T, et al.
Publicado: (2017)

P1664: IMPACT OF A PROTOCOL USING RITUXIMAB FOR PREVENTION OF RELAPSE IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP)
por: Marín Sánchez, E., et al.
Publicado: (2022)

Management of Perioperative Anticoagulation in a Patient with Antiphospholipid Antibody Syndrome Undergoing Cardiac Surgery: A Case Report
por: Malviya, Sanjana A., et al.
Publicado: (2022)

Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi
por: Park, Hyun Oh, et al.
Publicado: (2016)

Bilateral adrenal hemorrhage in antiphospholipid syndrome: Anticoagulation for the treatment of hemorrhage
por: Aldaajani, Hana, et al.
Publicado: (2018)

Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
por: Sanford, Zachary, et al.
Publicado: (2019)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

O25 Catastrophic antiphospholipid crisis triggered by anticoagulant switch
por: Andev, Rajinder Singh, et al.
Publicado: (2021)

P1654: IS THERE REALLY AN INCREASED RISK IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME UNDERGOING TO INVASIVE PROCEDURES?
por: Camacho, Rocio, et al.
Publicado: (2023)

PB2116: CASTLEMAN’S DISEASE: DIFFERENT CLINICAL BEHAVIOR AND PATHOLOGIC RECLASSIFICATION OF A COHORT OF MEXICAN PATIENTS
por: Collazo, Alfonso Orozco, et al.
Publicado: (2023)

Pharyngeal–Cervical–Brachial Variant of Guillain–Barré Syndrome
por: Moscona-Nissan, Alberto, et al.
Publicado: (2021)

The Catastrophic Antiphospholipid Syndrome
por: Rodríguez-Pintó, Ignasi, et al.
Publicado: (2014)

Book Review: El médico en la palestra: Diego Mateo Zapata (1664–1745) y la ciencia moderna en España
por: Amelang, James S
Publicado: (2006)

Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice
por: Kempers, Eva K, et al.
Publicado: (2021)

Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome
por: Giarretta, Igor, et al.
Publicado: (2022)

Lupus mastitis and antiphospholipid syndrome treated with anticoagulation and immunosuppression: a case report
por: He, Lauren J., et al.
Publicado: (2023)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

1664. Impact of a Midline Catheter Prioritization Project on Central Venous Access and Central Line Associated Bloodstream Infections at an Urban Safety-net Community Hospital
por: Mena Lora, Alfredo J, et al.
Publicado: (2022)

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review
por: Pires da Rosa, Gilberto, et al.
Publicado: (2022)

Neutrophil Extracellular Traps, Antiphospholipid Antibodies and Treatment
por: Bravo-Barrera, Jessica, et al.
Publicado: (2017)

Primary antiphospholipid syndrome presenting as thrombotic microangiopathy: Successful treatment with steroids, plasma exchange and anticoagulants
por: Sharma, R. K., et al.
Publicado: (2011)

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019)

Complete Resolution of a Large Bicuspid Aortic Valve Thrombus with Anticoagulation in Primary Antiphospholipid Syndrome
por: Rachwan, Rayan Jo, et al.
Publicado: (2017)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
por: Aubignat, M., et al.
Publicado: (2020)

Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
por: Schulz, Annabel, et al.
Publicado: (2022)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

Problems of Anticoagulant Control—II, Which Test?
por: Hamblin, T. J.
Publicado: (1971)

Cannot write session to /tmp/vufind_sessions/sess_72qf6drqr1944el6o8eobdosjh